Bain Capital Life Sciences Investors, LLC - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2023$13,514,550
-56.7%
915,000
-62.1%
1.51%
-53.0%
Q2 2023$31,201,800
+81142.0%
2,415,000
-38.3%
3.21%
-33.1%
Q1 2023$38,406
-7.8%
3,915,0000.0%4.80%
+3.1%
Q4 2022$41,656
-99.9%
3,915,000
-27.7%
4.66%
-31.0%
Q3 2022$56,533,000
-46.6%
5,415,000
-35.7%
6.75%
-45.7%
Q2 2022$105,945,000
+16.1%
8,415,0000.0%12.42%
+40.3%
Q1 2022$91,219,000
-23.0%
8,415,0000.0%8.86%
-5.6%
Q4 2021$118,399,000
-26.8%
8,415,0000.0%9.39%
-6.4%
Q3 2021$161,652,000
+39.4%
8,415,000
-28.5%
10.03%
+32.0%
Q2 2021$115,951,000
+8.3%
11,771,708
+8.0%
7.60%
+25.2%
Q1 2021$107,105,000
+127.5%
10,895,7730.0%6.07%
+38.3%
Q3 2020$47,070,000
-51.3%
10,895,7730.0%4.39%
-56.7%
Q2 2020$96,646,000
+213.6%
10,895,773
+24.8%
10.12%
+94.2%
Q1 2020$30,819,000
-36.3%
8,730,707
+3.3%
5.21%
-27.7%
Q4 2019$48,347,000
+59.8%
8,452,2350.0%7.21%
-7.5%
Q3 2019$30,259,0008,452,2357.79%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,415,000$105,945,00012.42%
Chicago Capital, LLC 5,842,906$73,562,0004.06%
PFM Health Sciences, LP 3,805,370$47,910,0001.83%
Rhenman & Partners Asset Management AB 800,000$10,072,0001.14%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,320,000$29,209,0000.71%
Rock Springs Capital Management LP 1,681,458$21,170,0000.62%
FEDERATED HERMES, INC. 16,022,731$201,726,0000.55%
FIRETHORN WEALTH PARTNERS, LLC 47,376$665,0000.54%
Jackson Creek Investment Advisors LLC 82,435$1,185,0000.48%
OBERWEIS ASSET MANAGEMENT INC/ 137,200$1,727,0000.44%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders